John F Sheridan Tandem Diabetes Care Inc (TNDM) insider trading activity

John F Sheridan is PRESIDENT & CEO of TANDEM DIABETES CARE INC. Currently has a direct ownership of 49,766 shares of TNDM, which is worth approximately $1.59 Million. The most recent transaction as insider was on Feb 27, 2023, when has been sold 308 shares (Common Stock) at a price of $35.87 per share, resulting in proceeds of $11,047. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 49.8K

9.2% 3M change

99.38% 12M change

Total Value Held $1.59 Million

John F Sheridan Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 27 2023	SELL Payment of exercise price or tax liability	$11,047 $35.87 p/Share	308 Reduced 2.01%	14,979 Common Stock
Feb 27 2023	BUY Exercise of conversion of derivative security	-	819 Added 5.09%	15,287 Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$13,924 $43.11 p/Share	323 Reduced 2.18%	14,468 Common Stock
Feb 15 2023	BUY Exercise of conversion of derivative security	-	792 Added 5.08%	14,791 Common Stock
Nov 28 2022	SELL Payment of exercise price or tax liability	$16,092 $39.54 p/Share	407 Reduced 2.83%	13,999 Common Stock
Nov 28 2022	BUY Exercise of conversion of derivative security	-	820 Added 5.39%	14,406 Common Stock
Nov 15 2022	SELL Payment of exercise price or tax liability	$16,654 $42.27 p/Share	394 Reduced 2.82%	13,586 Common Stock
Nov 15 2022	BUY Exercise of conversion of derivative security	-	793 Added 5.37%	13,980 Common Stock
Aug 29 2022	SELL Payment of exercise price or tax liability	$18,999 $46.68 p/Share	407 Reduced 2.99%	13,187 Common Stock
Aug 29 2022	BUY Exercise of conversion of derivative security	-	820 Added 5.69%	13,594 Common Stock
Aug 15 2022	SELL Payment of exercise price or tax liability	$21,713 $55.25 p/Share	393 Reduced 2.98%	12,774 Common Stock
Aug 15 2022	BUY Exercise of conversion of derivative security	-	792 Added 5.67%	13,167 Common Stock
May 27 2022	SELL Payment of exercise price or tax liability	$28,820 $70.81 p/Share	407 Reduced 3.18%	12,375 Common Stock
May 27 2022	BUY Exercise of conversion of derivative security	-	820 Added 6.03%	12,782 Common Stock
May 16 2022	SELL Payment of exercise price or tax liability	$116,092 $73.85 p/Share	1,572 Reduced 11.88%	11,656 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	-	3,170 Added 19.33%	13,228 Common Stock
May 16 2022	BUY Grant, award, or other acquisition	$18,718 $61.17 p/Share	306 Added 2.49%	11,962 Common Stock
May 09 2022	BUY Open market or private purchase	$174,750 $69.9 p/Share	2,500 Added 19.91%	10,058 Common Stock
Feb 28 2022	SELL Payment of exercise price or tax liability	$31,930 $112.43 p/Share	284 Reduced 3.62%	7,558 Common Stock
Feb 28 2022	BUY Exercise of conversion of derivative security	-	819 Added 9.46%	7,842 Common Stock
Nov 29 2021	SELL Payment of exercise price or tax liability	$52,772 $129.66 p/Share	407 Reduced 5.48%	7,023 Common Stock
Nov 29 2021	BUY Exercise of conversion of derivative security	-	820 Added 9.94%	7,430 Common Stock
Aug 27 2021	SELL Payment of exercise price or tax liability	$44,896 $110.31 p/Share	407 Reduced 5.8%	6,610 Common Stock
Aug 27 2021	BUY Exercise of conversion of derivative security	-	820 Added 10.46%	7,017 Common Stock
Aug 09 2021	SELL Open market or private sale	$1,036,068 $107.89 p/Share	9,603 Reduced 60.78%	6,197 Common Stock

Also insider at

AFIB

Acutus Medical, Inc. Healthcare

Director

JFS

John F Sheridan

PRESIDENT & CEO

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNDM shares.

Notify only if

Value

Insider Trading

Get notified when an Tandem Diabetes Care Inc insider buys or sells TNDM shares.

Notify only if

Operation

Value

Type

News

Receive news related to TANDEM DIABETES CARE INC

Track Activities on TNDM

Account